PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent

January 8, 2024

https://www.globenewswire.com/news-release/2024/01/08/2805880/0/en/PCP-Use-of-Clover-Assistant-Correlated-with-Increased-Medication-Fills-for-Patients-who-Were-Previously-Non-Adherent.html

FRANKLIN, Tenn., Jan. 08, 2024 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (NASDAQ:CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today released research demonstrating Clover Assistant’s impact on medication adherence. The paper, Clover Assistant Use and Medication Adherence for Common Chronic Conditions, examines the correlation between Primary Care Physician (PCP) use of Clover Assistant and levels of adherence to prescribed medications for common chronic conditions including diabetes, high blood pressure, and high cholesterol.

Read more at globenewswire.com

Related news for (CLOV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.